DEBRA LITKE: Open Payments
NPI 1578610945 · NEEDHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 18 payments from 7 companies in 2025. Trend: 2023 $1,646 · 2024 $344 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $127 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Incyte Corporation | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| LEO Pharma Inc. | 1 | $16 |
Products named: Bimzelx, TALTZ, SKYRIZI, Rhapsido, COSENTYX, RINVOQ, OPZELURA, Sotyktu.
Industry payments across MA — which companies pay providers there.
